AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2014

Jan 10, 2014

33819_dirs_2014-01-10_305be899-14dd-4e43-85ae-bb3bfa6444d2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2014-01-01

Reporting Person: WEISSMAN IRVING (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-01	Common Stock	A	39273	$0.00	Acquired	201109	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	19012	Indirect

Footnotes

F1: In accordance with Board action taken, this is an equity grant of 39,273 restricted stock units, vesting 100% on January 1, 2015, as compensation for Board service.

F2: Includes the following anniversary equity grants: (i) 10,000 restricted stock units vesting 100% on October 1, 2014, and (ii) 39,273 restricted stock units vesting 100% on January 1, 2015.

F3: Includes 10,508 shares held in trust for Dr. Weissman's grandchildren. Dr. Weissman disclaims beneficial ownership of such shares